Skip to main content
ross-boyce
Ross Boyce, MD

From clinicians to first responders, respiratory therapists, housekeepers, and food service workers, a wide range of North Carolina’s healthcare workers have enrolled in a new online research community to share the perspectives and problems faced by those on the COVID-19 pandemic front lines and to help find solutions.

The Healthcare Worker Exposure Response & Outcomes (HERO) Registry unites a diverse group of essential workers across North Carolina and around the country in an online community to facilitate rapid-cycle research, including an ongoing randomized clinical trial to investigate if hydroxychloroquine (brand name Plaquenil®) can protect healthy, at-risk workers from COVID-19.

Ross Boyce, MD, assistant professor in the UNC Department of Medicine in the division of infectious diseases is the UNC-Chapel Hill site leader.

“Despite all the recent news about hydroxychloroquine, the HERO-HCQ study will answer important and still unresolved questions about the potential role of the drug as prophylaxis against COVID-19,” said Boyce. “Now more than ever, it is imperative that we have robust evidence from randomized, placebo-controlled trials like the HERO-HCQ study. So frequently, we are the ones asking our patients to participate in clinical trials. Now all of us (healthcare workers) have a chance to contribute as well.”